HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of Epstein-Barr virus latent membrane protein 2 specific T-cell receptors driven by T-cell specific promoters using lentiviral vector.

Abstract
Transduction of latent membrane protein 2 (LMP2)-specific T-cell receptors into activated T lymphocytes may provide a universal, MHC-restricted mean to treat EBV-associated tumors in adoptive immunotherapy. We compared TCR-specific promoters of distinct origin in lentiviral vectors, that is, Vβ6.7, delta, luria, and Vβ5.1 to evaluate TCR gene expression in human primary peripheral blood monocytes and T cell line HSB2. Vectors containing Vβ 6.7 promoter were found to be optimal for expression in PBMCs, and they maintained expression of the transduced TCRs for up to 7 weeks. These cells had the potential to recognize subdominant EBV latency antigens as measured by cytotoxicity and IFN-γ secretion. The nude mice also exhibited significant resistance to the HLA-A2 and LMP2-positive CNE tumor cell challenge after being infused with lentiviral transduced CTLs. In conclusion, LMP2-specific CTLs by lentiviral transduction have the potential use for treatment of EBV-related tumors.
AuthorsDongchang Yang, Qing Shao, Hua Sun, Xiaoxin Mu, Yun Gao, Runqiu Jiang, Jiajie Hou, Kun Yao, Yun Chen, Beicheng Sun
JournalClinical & developmental immunology (Clin Dev Immunol) Vol. 2011 Pg. 716926 ( 2011) ISSN: 1740-2530 [Electronic] Egypt
PMID21969838 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • EBV-associated membrane antigen, Epstein-Barr virus
  • HLA-A2 Antigen
  • Receptors, Antigen, T-Cell
  • Viral Matrix Proteins
Topics
  • Animals
  • Carcinoma
  • Cell Line
  • Epstein-Barr Virus Infections (immunology, therapy, virology)
  • Genetic Vectors
  • HLA-A2 Antigen (genetics, metabolism)
  • Herpesvirus 4, Human (immunology)
  • Humans
  • Immunotherapy, Adoptive
  • Lentivirus (genetics)
  • Mice
  • Mice, Nude
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms (therapy)
  • Promoter Regions, Genetic
  • Receptors, Antigen, T-Cell (classification, genetics, metabolism)
  • T-Lymphocytes (immunology, metabolism, virology)
  • T-Lymphocytes, Cytotoxic (immunology, virology)
  • Transduction, Genetic
  • Viral Matrix Proteins (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: